Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac - Hallo friend American jobs and vicinity, In the article you read this time with the title Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac, we have prepared well for this article you read and download the information therein. hopefully fill posts Article bank, Article contracting, Article general, Article health, Article manufacturing, Article marketing, Article teachers, Article telecommunications, Article The latest, we write this you can understand. Well, happy reading.

Title : Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac
link : Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac

Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac

In PLOS One, a new paper on repugnance and risk perception:

When money talks: Judging risk and coercion in high-paying clinical trials
Christina Leuker ,Lasare Samartzidis,Ralph Hertwig,Timothy J. Pleskac
Published: January 31, 2020

Abstract
Millions of volunteers take part in clinical trials every year. This is unsurprising, given that clinical trials are often much more lucrative than other types of unskilled work. When clinical trials offer very high pay, however, some people consider them repugnant. To understand why, we asked 1,428 respondents to evaluate a hypothetical medical trial for a new Ebola vaccine offering three different payment amounts. Some respondents (27%) used very high pay (£10,000) as a cue to infer the potential risks the clinical trial posed. These respondents were also concerned that offering £10,000 was coercive— simply too profitable to pass up. Both perceived risk and coercion in high-paying clinical trials shape how people evaluate these trials. This result was robust within and between respondents. The link between risk and repugnance may generalize to other markets in which parties are partially remunerated for the risk they take and contributes to a more complete understanding of why some market transactions appear repugnant.

Thus Article Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac

that is all articles Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac This time, hopefully can provide benefits to all of you. Okay, see you in another article post.

You now read the article Repugnance and risk perception in paid clinical trials, by Leuker, Samartzidis, Hertwig and Pleskac with the link address https://americanjobsandvicinity.blogspot.com/2020/03/repugnance-and-risk-perception-in-paid.html

Tweet

Subscribe to receive free email updates: